课题基金 / 基金详情

ZONISAMIDE VERSUS PLACEBO

ZONISAMIDE VERSUS PLACEBO
唑尼沙胺与安慰剂
批准号:
7607645
负责人:
ALBERT JOSEPH ARIAS
金额:
$0.53万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31

项目摘要

项目成果

ALBERT JOSEPH ARIAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a pilot study designed to examine the potential efficacy and tolerability of zonisamide for the treatment of alcoholism, and to compare this to topiramate, a similar medicine with demonstrated efficacy in a randomized clinical trial. Zonisamide is potentially better tolerated and easier to titrate in the outpatient setting than topiramate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
  • 批准号:
    10615366
  • 项目类别:
  • 资助金额:
    $159.79万
  • 财政年份:
    2022
  • 负责人:
    ALBERT JOSEPH ARIAS
  • 依托单位:
Olanzapine Augmentation in OUD Patients on Buprenorphine-Naloxone with Comorbid Symptoms of Serious Mental Illness (SMI): A Prospective Observational 8-week Pilot Study
  • 批准号:
    10395719
  • 项目类别:
  • 资助金额:
    $14.73万
  • 财政年份:
    2021
  • 负责人:
    ALBERT JOSEPH ARIAS
  • 依托单位:
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders
  • 批准号:
    10553087
  • 项目类别:
  • 资助金额:
    $64.71万
  • 财政年份:
    2020
  • 负责人:
    ALBERT JOSEPH ARIAS
  • 依托单位:
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders
  • 批准号:
    9894325
  • 项目类别:
  • 资助金额:
    $51.25万
  • 财政年份:
    2020
  • 负责人:
    ALBERT JOSEPH ARIAS
  • 依托单位:
海外基金